vision changes semaglutide A new study published in the Open Access journal Pharmaceutics shows that semaglutide, also known as Ozempic, has therapeutic potential for protection against loss in people with diabetes. , Northeast Ohio woman reports vision

Ozempic is about to be old news, my colleague Yasmin Tayag wrote in 2023, just before an even more powerful obesity drug, tirzepatide, then best known as Mounjaro, was approved

But until now, there hasnt been any data from large epidemiologic studies. To help fill this knowledge gap, UBC researchers examined health insurance claim records for approximately 16 million U.S

Doctors also consider which medication is best for the patient

Metabolic Support Semaglutide may improve insulin sensitivity and glucose metabolism, making it relevant for both diabetes and obesity-related research

The move gives Canadian patients a regulated copy of Novo Nordisks Ozempic years before U.S